Background {#Sec1}
==========

Massively parallel, short-read sequencing has profoundly transformed genomics research \[[@CR1], [@CR2]\] and has become the dominant technology for sequencing DNA. However, one inherent limitation of most current technologies is that the sequencing run must finish before data analysis can begin. As a result, sequence analysis algorithms have been designed to make inference on a complete sequencing data set. In contrast, streaming algorithms are applied to a sequence of data events and typically maintain an internal summary of the data, as well as an approximation of the full inference, without needing to store all of the observations \[[@CR3]\]. Streaming algorithms have applications in particle and solar physics, computer network analysis and finance \[[@CR4]\].

Oxford Nanopore Technologies has recently released a portable MinION sequencing device, which utilises nanopore sequencing technology originally proposed in the 1990s \[[@CR5]\]. The key innovation of this device is that it measures changes in electrical current as single-stranded DNA passes through the nanopore and uses the signal to determine the nucleotide sequence of the DNA strand \[[@CR6], [@CR7]\]. These sequence data can be retrieved and analysed as they are generated, providing the opportunity to obtain answers in the shortest possible time. Real-time sequencing has many potential applications, especially in time-critical areas such as rapid clinical diagnosis.

In order to realise this potential there is a need to develop streaming bioinformatics algorithms that continually update and report results as each sequence read is generated. To be of practical use -- for example to know when to make a diagnosis in the clinic -- these algorithms must continuously update not only a point estimate (*e.g.*, which species are present and their proportions), but also confidence intervals in that estimate. Several systems incorporating real-time analysis of MinION data have been developed recently, such as the cloud-based platform Metrichor (Oxford Nanopore), work by Quick et al. \[[@CR8]\] and MetaPORE \[[@CR9]\], which place the sample on a phylogenetic tree but without estimating the confidence in this assignment.

Here we present a flexible framework for the real-time analysis of MinION sequence data directly as it is sequenced and base-called. The framework can incorporate multiple real-time analyses to suit the problems at hand and can be deployed on a single computer or on a high-performance computing facility and computing cloud. We also present four streaming algorithms for the identification and characterisation of pathogen samples. These algorithms, which are seamlessly integrated into the pipeline, report analysis results along with their confidence levels so that users can decide when to stop a sequencing run.

By sequencing four bacterial isolate samples and a mixture sample on the MinION sequencer, we demonstrate that we can reliably determine the species and strain of a sequenced sample with only 500 reads. This was achieved in less than half an hour of sequencing with the current throughput of the MinION. Furthermore, we show that we can identify most of the drug resistance genes present in a sample within 2 h of sequencing, and the full drug resistance profile within 10 h. The pipeline can perform all these analyses on a single computer at a throughput of over 100 times higher than our best runs. As the throughput of nanopore sequencing is expected to increase, the time to obtain these results will be significantly shortened. Our findings support the potential use of MinION sequencing for the real-time analysis of clinical samples for species detection and analysis of antibiotic resistance.

Results and discussion {#Sec2}
======================

Real-time analysis framework {#Sec3}
----------------------------

Our real-time analysis framework consists of several of *streaming* programs communicating to each other via the network sockets or inter-process communication pipes provided by Unix-like operating systems. These programs typically take a sequence of items as input and process them every time a given small number of items arrive. They either retain only the relevant statistics of the data, or upon processing any data items, immediately forward only the necessary information to the downstream programs for further processing. This data processing methodology requires only a small memory footprint and hence is relevant for processing large amounts of data, especially real-time data from MinION sequencing.

We developed a number of auxiliary programs to facilitate setting up a real-time pipeline to analyse MinION sequencing data. These include scripts for setting up communication channels in a pipeline, thereby allowing the pipeline to be deployed on a high-performance computing cluster to scale with massive amounts of data. Programs for simple analyses of MinION sequencing data such as initial analysis (npReader \[[@CR10]\]) and read-filtering on the basis of read length and read quality are also provided.

We also developed streaming algorithms for a handful of identification problems, namely species typing, strain typing and identification of antibiotic resistance profiles (see [Methods](#Sec14){ref-type="sec"}). We integrated the implementations of these algorithms into the analysis pipeline (see Fig. [1](#Fig1){ref-type="fig"}). In this pipeline, npReader \[[@CR10]\] continuously scans the folder containing sequencing data in parallel with MinION sequencing. It picks up sequenced reads as soon as they are generated (from Metrichor), and simultaneously streams them through the pipeline for identification analyses. The pipeline also makes use of off-the-shelf bioinformatics tools such as BWA-MEM \[[@CR11]\], as described later. In each step of this pipeline, data are piped from one process to the next without being written to disk, with the exception of base-calling via Metrichor in which each read is written to disk once it has been base-called, and is then picked up almost immediately by npReader. Fig. 1Schematic of the real-time analysis pipeline. Once the MinION starts sequencing, DNA fragments are sequenced (on the MinION) and base-called (by Metrichor cloud) instantaneously, and are simultaneously streamed through the pipeline where they are aligned by BWA-MEM \[[@CR11]\]. *Arrows* show the data flow

We evaluated our real-time analysis pipeline and the accuracy of our algorithms using five MinION sequencing data sets. Four of these data sets were collected before the pipeline was developed, and hence we emulated the timing of the sequencing for the evaluation from these data sets. Specifically, we extracted the time that each read was sequenced, and streamed the sequence reads in the exact order and timing into the pipeline. With the emulation, we were able to stream the sequencing data at a hypothetical throughput 120 times higher than that we obtained with the MinION. This allowed us to test the scalability of the pipeline against the projected future throughput such as from the PromethION platform. The fifth data set was passed through our pipeline as it was base-called from Metrichor, and thus represents a true demonstration of the real-time capability of the pipeline. Finally, we validated the analysis results by sequencing these samples with the Illumina MiSeq platform, which has well-established bioinformatics analysis methods.

Data generation {#Sec4}
---------------

We prepared samples from cultured isolates of two *Klebsiella pneumoniae* strains ATCC BAA-2146, ATCC 13883; one *Klebsiella quasipneumoniae* strain ATCC 700603 and a library mixture sample. This mixture sample contained two different sequencing libraries prepared from the *Escherichia coli* strain ATCC 25922 and the *Staphylococcus aureus* strain ATCC 25923, pooled at different levels prior to sequencing (Table [1](#Tab1){ref-type="table"}). We sequenced sample ATCC BAA-2146 and ATCC 700603 with the MinION using chemistry R7 and the others using the improved chemistry R7.3 (see [Methods](#Sec14){ref-type="sec"}). Table 1Details of the four samplesSampleSpeciesStrainInformationProportionSingle sample 1*K. pneumoniae*ATCC BAA-2146NDM-1 positive resistant100 %Single sample 2*K. quasipneumoniae*ATCC 700603K6, ESBL100 %Single sample 3*K. pneumoniae*ATCC 13883Type strain100 %Mixture sample*E. coli*ATCC 25922Seattle 194675 %(Library mix)*S. aureus*ATCC 25923Seattle 1945, Methicillin sensitive25 %

To validate the analysis results from MinION sequencing, we sequenced all aforementioned isolates with the established Illumina platform MiSeq to a coverage exceeding 100-fold. Isolates in the mixture sample were sequenced separately. We assembled the MiSeq sequencing reads to obtain high quality assemblies of the five strains. With the assemblies, we were able to identify the sequence types and the antibiotic resistance profiles of these strains (see [Methods](#Sec14){ref-type="sec"}). These results were used as the benchmarks to validate the analysis of MinION sequencing data.

Sequencing yields and quality of MinION sequencing {#Sec5}
--------------------------------------------------

Sequence reads from the MinION were classified into three types: *template*, *complement* and higher quality *2D* reads (*i.e.*, reads resulted from computationally merging a template and a complement read). The average Phred quality of template and complement reads across four runs was in the region of 5, while 2D reads were in higher quality, with average Phred quality about 9 (see Table [2](#Tab2){ref-type="table"} and Additional file [1](#MOESM1){ref-type="media"}: Figure S1). The median read lengths of three *K. pneumoniae* samples were approximately 5 Kb, while the mixture sample was only less than 1 Kb. We observed variation in terms of sequence yields across the four runs. While we obtained about 36 000 reads (185 Mb) for sample *K. pneumoniae* ATCC BAA-2146 after 60 h of sequencing, the run for sample *K. quasipneumoniae* ATCC 700603 yielded only 7092 reads (39 Mb) with the same running time (Fig. [2](#Fig2){ref-type="fig"}). We sequenced sample *K. pneumoniae* ATCC 13883 and the mixture sample for 36 and 20 h respectively, both with the chemistry 7.3, but the yields were markedly different. The read length and accuracy of our runs were consistent with other user reports \[[@CR12]--[@CR15]\]. Fig. 2Sequencing yields over time for the four samples. Yields are shown in terms of read count (*left*) and base count (*right*)Table 2Details of the four MinION sequencing runsSampleChemistryBasecallTimeReadBaseMedianQualityQuality 2Dversion(hrs)countcount (Mb)lengthmean (std)mean (std)Single sample 1R71.4603816518545804.70 (0.91)8.96 (0.63)Single sample 2R71.46072933949364.95 (1.2)9.34 (0.87)Single sample 3R7.31.936159118652424.58 (1.7)9.46 (1.48)Mixture sampleR7.31.10215631128255.44 (2.1)10.72(2.41)Read quality in Phred score

Species detection {#Sec6}
-----------------

For real-time bacterial species detection, we built a database from 2785 complete genomes of 1489 bacterial species available in GenBank (accessed Nov 2014), augmented with two *K. quasipneumoniae* genomes (which was not the strain we sequenced) as none were present in the database. The database contained several *K. pneumoniae*, *E. coli* and *S. aureus* strains (10, 63 and 49 respectively), but none of the five strains in our samples were present. The pipeline aligns sequence reads as they are generated from the sequencer to this database. The species typing algorithm periodically computes the simultaneous proportions of the species present in the sample and reports the 95 % confidence intervals of these proportions (see [Methods](#Sec14){ref-type="sec"}).

In both *K. pneumoniae* samples as well as the *K. quasipneumoniae* sample, we successfully detected the major species present in the isolate. This was achieved with as little as 120 sequence reads requiring only 5 min of sequencing time (Fig. [3](#Fig3){ref-type="fig"}[a](#Fig3){ref-type="fig"}, [b](#Fig3){ref-type="fig"} and [c](#Fig3){ref-type="fig"}). For *K. pneumoniae* strains ATCC BAA-2146 and ATCC 13883, it required less than 500 reads (10 and 15 min of sequencing, respectively) to reach a 95 % confidence interval of less than 0.05. For strain ATCC 700603 it required only 300 reads to correctly identify *K. quasipneumoniae* as the species. Fig. 3Real-time identification of bacterial species from MinION sequencing data for four different bacterial samples: a) *K. pneumoniae* ATCC BAA-2146, b) *K. quasipneumoniae* ATCC 700603, c) *K. pneumoniae* ATCC 13883 and d) Mixture of 75 % *E. coli* ATCC 25922 and 25 % *S. aureus* ATCC 25923. The *bars* represent confidence intervals at the 95 % level

The pipeline accurately identified the two species in the mixture sample as *E. coli* and *S. aureus* after obtaining around 100 reads (5 min of sequencing). The reported proportions became stable after around 1200 reads (35 min of sequencing). *E. coli* was the predominant species type in the mixture sample and it was evident with high proportion of sequencing reads supporting the *E. coli* species.

Multi-locus sequence typing {#Sec7}
---------------------------

Most bacteria are conventionally strain-typed using a multi-locus sequence typing (MLST) system that requires accurate genotyping to distinguish the alleles of seven house-keeping genes \[[@CR16]\]. Our analysis of MinION raw read quality (Additional file [1](#MOESM1){ref-type="media"}: Figure S1), together with other user reports \[[@CR12]--[@CR15]\], indicated high error rates in MinION sequencing in comparison to Illumina Miseq sequencing. This suggested that MLST analysis would be challenging with MinION sequence data, especially in real-time fashion.

We developed a method to carry out MLST using MinION sequence data. Our method selected reads spanning each of the house-keeping genes. It then used multiple reads aligned to the same gene to correct error in the raw sequence reads and subsequently combined information across multiple alleles in a likelihood-based framework (see [Methods](#Sec14){ref-type="sec"}). Table [3](#Tab3){ref-type="table"} presents the top five highest score sequence types (in log-likelihood) for *K. pneumoniae* and *K. quasipneumoniae* strains using MinION sequencing. In all three strains, the correct sequence types were the highest score out of 1678 sequence types available in the MLST database. We noticed that the typing system also outputted several other sequence types with the same likelihood (*e.g.*, ST-751 and ST-864 for strain ATCC BAA-2146 and ST-851 for strain ATCC 700603). We examined the profiles of these sequence types, and found them to be highly similar. For example, sequence types ST-751 and ST-864 (reported for strain ATCC BAA-2146) differed to the correct sequence type ST-11 by only one single nucleotide polymorphism (SNP) from the total of 3012 bases in seven genes. Similarly, sequence type ST-851 (co-highest score reported for strain ATCC 700603) differed to the correct sequence type ST-489 by two alleles (genes *phoE* and *tonB*). Because the run had a poor yield, only one read was aligned to these two genes by the end of the run, which may have also contributed to the inability to differentiate these two sequence types. While the results were encouraging, this also suggested that traditional MLST with nanopore sequencing requires high coverage to report the sequence type with absolute certainty. A more accurate strain-typing methodology would need to consider all of the sequenced reads, rather than just those 7 house-keeping genes. Therefore we further devised a method for strain-typing which was based on presence or absence of genes. Table 3MLST results for three *K. pneumoniae* strainsATCC BAA-2146ATCC 700603ATCC 13883ST-11ST-489ST-3RankTypeScoreTypeScoreTypeScore1**ST-111985.47ST-489418.45ST-31451.65**2**ST-7511985.47ST-851418.45**ST-1361450.213**ST-8641985.47**ST-257413.57ST-381444.814ST-10801984.46ST-356413.57ST-11061444.195ST-16801982.62ST-414413.57ST-9311441.44The top five probable sequence types are shown for each sample. The highest score sequence types are highlighted in bold

Strain typing by presence or absence of genes {#Sec8}
---------------------------------------------

We developed a novel strain typing method to identify a known bacterial strain from the MinION sequence reads based on patterns of gene presence and absence. This approach is intended to rapidly identify the presence of a sequence type that has already been characterised, for example in an outbreak scenario, with subsequent confirmation using MLST once more data has been collected. We downloaded the genome assemblies of all strains for *K. pneumoniae*, *E. coli* and *S. aureus* species from the RefSeq repository and identified their sequence types using the relevant MLST schemes. This resulted in sets of 125 sequence types for *K. pneumoniae*, 353 for *E. coli* and 107 for *S. aureus*. For each sequence type, we picked the highest quality assembly (in terms of N50 statistics) and extracted gene sequences from its RefSeq gene annotation. We then grouped genes from a species based on 90 % sequence identity, and therein obtained the gene profile for each sequence type.

Our pipeline identified genes present in the sample from sequence reads as they were generated by the MinION device. It then used this information to infer the posterior probability of each of the sequence types, as well as the 95 % confidence intervals in this estimate (see [Methods](#Sec14){ref-type="sec"}). For our *K. pneumoniae* and *K. quasipneumoniae* samples, we successfully identified the corresponding sequence types from the sequence data with 95 % confidence within 10 min of sequencing time and with as few as 200 sequence reads (Fig. [4](#Fig4){ref-type="fig"}[a](#Fig4){ref-type="fig"}, [b](#Fig4){ref-type="fig"} and [c](#Fig4){ref-type="fig"}). We streamed sequence reads from the mixture sample through the strain typing systems for *E. coli* and *S. aureus*, and in both cases, the correct sequence types of two species in the sample were also recovered. The correct sequence type for *E. coli* strain in the 75 %/ 25 % *E. coli*, *S. aureus* mixture was recovered after 25 min of sequencing with about 1000 total reads (or approximately 750 *E. coli* derived reads) (Fig. [4](#Fig4){ref-type="fig"}[d](#Fig4){ref-type="fig"}). The pipeline was able to correctly predict the *S. aureus* strain (which is known to have much less gene content variation) in this mixture sample after 2 h of sequencing with about 2800 total reads (or approximately 700 *S. aureus* derived reads). Fig. 4Real-time strain identification from MinION sequencing data on three different *K. pneumoniae* strains (**a**, **b** and **c**) and a *E. coli* strain (**d**) and a *S. aureus* strain (**e**) from the mixture sample. The *bars* represent confidence intervals at the 95 % level

Antibiotic resistance detection {#Sec9}
-------------------------------

The antibiotic resistance gene profiles of the samples were also characterised with MinION sequencing data. We obtained antibiotic drug resistance genes from the *ResFinder* database \[[@CR17]\] (accessed July 2015). This set contained 2132 gene sequences, including variants of the same genes. We grouped these gene sequences based on 90 % sequence identity into 609 groups. In this grouping, we found that sequences in a group were variants of the same gene.

Our antibiotic resistance profile identification pipeline aligned sequence reads to this antibiotic gene database. The algorithms retained reads that aligned to these genes, and periodically performed multiple alignment of reads that were aligned to the same gene. It then generated a consensus sequence from these reads, and used a probabilistic Finite State Machine \[[@CR18]\] to re-align the consensus sequence to the gene sequence (see [Methods](#Sec14){ref-type="sec"}). The pipeline reported the presence of a resistance gene as soon as the alignment score reached a threshold.

Table [4](#Tab4){ref-type="table"} shows the time-line of antibiotic gene detection from MinION sequencing of three *K. pneumoniae* strains. For the NDM-1-producing strain ATCC BAA-2146, we identified the presence of 26 antibiotic resistance genes in the MiSeq assembly of the strain. Our real-time pipeline identified all these 26 genes and an additional gene *blaSHV* from 10 h of MinION sequencing. No further genes were detected thereafter. As gene *blaSHV* was reported with high confidence from the real-time analysis, we further investigated the alignment of the MiSeq assembly with this gene, and found that the gene was aligned to two contigs in the assembly suggesting the MiSeq assembly was fragmented in the middle of the gene. We sourced a high quality assembly of the strain's genome using PacBio sequencing \[[@CR19]\] and found that the assembly contained the gene. In other words, our pipeline detected precisely the antibiotic gene profile for this strain from 10 h of MinION sequencing. We observed that the majority of these genes were identified in the early stage of sequencing, *i.e.*, three quarters were reported within 1.5 h of sequencing, at fewer than 4000 reads (making up only a 3-fold coverage of the genome). We observed similar performance for *K. pneumoniae* strain ATCC 13883 where 5 out of 6 genes were detected after 2 h of sequencing. The last gene (*oqxB*) was detected after 9.5 h of sequencing, again recovering the full resistance profile without any false positive. For the multi-drug resistant *K. quasipneumoniae* strain ATCC 700603, the pipeline only detected 8 out of 11 genes. The reduced sensitivity for this sample was most likely due to the low sequence yield (33 Mb of data in total, or only 7-fold coverage of the genome). Table 4Time-line of resistance gene detection from the *K. pneumoniae* samplesTimegenesClassTP/FPSensitivitySpecificityData(mins)(%)(%)(no. of reads)*K. pneumoniae* ATCC BAA-2146301228mphAmacrolideTPblaSHVbeta-lactamaseFP ^∗^strAaminoglycosideTPblaTEMbeta-lactamaseTPstrBaminoglycosideTPblaCTXbeta-lactamaseTP26.6787.50602613blaLENbeta-lactamaseTPsul2sulphonamideTPblaOXAbeta-lactamaseTPaac3aminoglycosideTPaac6aminoglycosideTPblaCMYbeta-lactamaseTPblaCFEbeta-lactamaseTPblaLATbeta-lactamaseTPblaBILbeta-lactamaseTP53.3394.12903844QnrBquinoloneTPaadAaminoglycosideTPoqxAquinoloneTPtetAtetracyclineTPoqxBquinoloneTP76.6795.831205258dfrAtrimethoprimTP80.0096.0024010 788blaOKPbeta-lactamaseTP83.3396.1527011 931rmtCaminoglycosideTP86.6796.4330013 022sul1sulphonamideTPsul3sulphonamideTP93.3396.5554020 200fosAfosfomycinTP96.6796.6760021 546blaNDMbeta-lactamaseTP100.0096.77*K. quasipneumoniae* ATCC 70060330582oqxAquinoloneTPblaSHVbeta-lactamaseTPoqxBquinoloneTP27.27100.00601090aadBaminoglycosideTP36.36100.003903704sul1sulphonamideTPsul3sulphonamideTP54.55100.004203810blaOXAbeta-lactamaseTP63.64100.005404156blaOKPbeta-lactamaseTP72.73100.00*K. pneumoniae* ATCC 13883301264fosAfosfomycinTP16.67100.00602186blaSHVbeta-lactamaseTPblaOKPbeta-lactamaseTP50.00100.00902952blaLENbeta-lactamaseTP66.67100.001203584oqxAquinoloneTP83.33100.005708112oqxBquinoloneTP100.00100.00TP/FP: true positives/false positives according to the resistance gene profiles obtained from MiSeq sequencing. ^∗^Gene blaSHV was detected from MinION sequencing of *K. pneumoniae* ATCC BAA-2146 but not from MiSeq sequencing due to the inability to resolve a repeat in the gene

Comparison with other methods {#Sec10}
-----------------------------

To date, only a few pipelines exist to identify species/subspecies from nanopore sequencing data, namely Metrichor \[[@CR8], [@CR20]\] and MetaPORE \[[@CR9]\]. These methods commonly place the sample of question to a phylogeny taxonomy based on the number of reads that either are aligned to, or have a similar k-mer profile to, the taxon's reference genome. Our species typing method is somewhat similar to this approach, although it additionally estimates confidence intervals in the species assignment. While we found that this approach can successfully identify species within 500 reads, the signal-to-noise from nanopore sequencing is too low to use a similar approach to correctly discriminate at the strain level, unless a large amount of data is available. Our strain typing uses a novel approach based on the presence and absence of genes and hence is able to make inference from a smaller number of reads.

Among the mentioned methods, only Metrichor \[[@CR20]\] and MetaPORE \[[@CR9]\] support genuine real-time analysis. As MetaPORE only focuses on viral species identification, we could only directly compare the performance of our method to Metrichor. We uploaded the first 1000 reads from our single samples and the first 3000 reads from our mixture sample to the Metrichor What's In My Pot Bacteria k24 for SQK-MAP005 v1.27 (WIMP) workflow. Along with the species/subspecies and strains reported, WIMP provides a *classification score* filter where users can set the permissiveness of reporting. Table [5](#Tab5){ref-type="table"} presents the bacterial taxa reported by the WIMP workflow for our data with the default classification score. For sample *K. pneumoniae* ATCC BAA-2146, WIMP only returned the taxon *K. pneumoniae* at the species level. On the other hand, for the second and third samples (*K. quasipneumoniae* ATCC 700603 and *K. pneumoniae* ATCC 13883), WIMP reported several *K. pneumoniae* strains, but not the correct sequence types of these samples (ST489 and ST3). For the mixture sample, two *E. coli* and three *S. aureus* strains were reported, but these were also the incorrect sequence types (*E. coli* ST73 and *S. aureus* ST243). While it was unclear whether the sequence types of these samples were included in WIMP's database, ST11 clearly was as it was reported in sample *K. pneumoniae* ATCC 700603. However, WIMP was unable to identify sample *K. pneumoniae* ATCC BAA-2146 to the strain level with 1000 reads, while our pipeline could do so in less than 400 reads (Fig. [4](#Fig4){ref-type="fig"}). Table 5Report of Metrichor What's In My Pot Bacteria k24 for SQK-MAP005 v1.27 (WIMP) from the first 1000 reads of three single samples and the first 3000 reads of the mixture sampleSampleReported by MetrichorSequence typeLevelAccuracyspecies/strain*K. pneumoniae* (ATCC BAA-2146, ST11)*K. pneumoniae*-Species$\documentclass[12pt]{minimal}
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                \begin{document}$\checkmark $\end{document}$) or incorrect (×) at species/strain levels. The Metrichor was able to identify the species (with some false positives) but not the strains in our samples^\*^ *K. quasipneumoniae* ATCC 700603 strain was recently re-classified from *K. pneumoniae* as *K. quasipneumoniae* \[[@CR49]\] but has not been updated in most major databases

Our species typing module has some similarities to the approach used by MetaPhlAn \[[@CR21]\], which was designed for metagenomics inference using millions of short-reads. Like MetaPhlAn, we used the proportion of reads that map to different taxonomic groupings to estimate the proportion of different species in a sample. MetaPhlAn optimises computational speed by aligning to a precomputed database of sequences that are pervasive within a single taxonomic grouping but not seen outside that grouping. This allows it to blast against a database that is 20 times smaller than a full bacterial genomic database. Our species typing approach, on the other hand, is designed to make a similar inference using only hundreds of reads, and moreover, also continuously updates confidence intervals so the user knows when they can stop sequencing and make a diagnosis.

Antibiotic resistance gene detection from MinION sequencing was also explored in Judge et al. \[[@CR22]\]. Their approach was broadly similar to ours in that it initially aligned sequence reads to a resistance gene database, and then constructed a consensus sequence from the multiple alignment of matched reads. Both pipelines reported close to perfect resistance gene identification when compared with Illumina MiSeq sequencing. However, our pipeline uses a novel alignment parameter estimation using probabilistic Finite State Machines (see [Methods](#Sec14){ref-type="sec"}). It is hence able to confidently report the presence of a resistance gene as soon as sufficient supporting data are available. This is the essence of real-time analysis presented here.

Computational time {#Sec11}
------------------

In our analyses, sequence reads were streamed through the pipeline in the exact order and timing that they were generated. Analysis results were generated periodically (every minute for species typing and strain typing and every five minutes for resistance gene identification). We examined the scalability of the pipeline to higher throughput by running the pipeline on a single computer equipped with 16 CPUs and streaming all sequence reads from the highest yield run (185 Mb from sample *K. pneumoniae* ATCC BAA-2146) through the pipeline at 120 times higher speed than they were generated (*e.g.*, data sequenced in 2 min were streamed within 1 s). Analysis results were generated every 5 s for typing and every one minute for gene resistance analysis. With this hypothetical throughput, our pipeline correctly identified the species and strain of the sample in less than 20 s; thereupon we could terminate the typing analyses. The pipeline then reported all the resistance genes in five minutes, which corresponded to the data generated in the first 10 h of actual sequencing. This demonstrates the scalability of our pipeline to higher throughput sequencing platforms in the future.

Real-time analysis of a clinical isolate {#Sec12}
----------------------------------------

With the pipeline in place, we analysed a clinical *K. pneumoniae* isolate collected in Greece that was found to be resistant to an extensive range of antibiotics. We sequenced the sample on the MinION with Chemistry R7.3 and ran the Metrichor service, which performed basecalling and sample identification during the first three hours of the run. We also ran our pipeline in real-time on the base-called data returned from the Metrichor service.

We observed a delay from the base-calling of the data; the first read was sequenced on the MinION within one minute from starting the run, but the base-called data were received after 6 min. The delay tended to increase as more data were generated. We found the base-called data returned during the three-hour run of the Metrichor service were actually sequenced within 45 min on the MinION. This highlights the need for a local base-calling step to improve real-time analysis. Figure [5](#Fig5){ref-type="fig"}[a](#Fig5){ref-type="fig"} and [5](#Fig5){ref-type="fig"}[b](#Fig5){ref-type="fig"} show the timing (from the start of the MinION run) of sample identification using our pipeline. The pipeline reported *K. pneumoniae* as the only species in the sample within 10 min, and reached a confidence interval of less than 0.1 in 40 min when approximately 200 reads were analysed. We noticed that these 200 reads were actually sequenced in 7 min by the MinION. For strain identification, our pipeline initially reported ST1199 but after 2.5 h, reported ST258 as the sequence type for this isolate. It is worth noting that the two strains are highly similar; their MLST profiles differ by only one SNP in the seven house-keeping genes. By sequencing the isolate on the Illumina MiSeq as described above, we confirmed that the sequence type for the strain is ST258. On the other hand, the sample identification from Metrichor initially reported *K. pneumoniae* 1084 (ST23), but finally reported two strains namely *K. pneumoniae* JM45 (ST11) and *K. pneumoniae* HS11286 (ST11) after 3 h (Additional file [2](#MOESM2){ref-type="media"}: Figure S2). During the three-hour run with less than 4000 reads (16 Mb of data), our pipeline reported two antibiotic resistance genes, namely *sul2* (sulphonamide) and *tetA* (tetracycline). Our analysis of the Illumina data for this strain confirmed the presence of these two genes. Clinical susceptibility testing also showed the resistance of this isolate to tetracycline and sulfamethoxazole-trimethoprim (MIC ≥ 16 *μ*g/mL and ≥ 320 *μ*g/mL, respectively analyzed by VITEK®;2 bioMérieux, Inc). Finally, we re-analysed the data from this run using the emulation described previously, and obtained the same results as from the real-time analysis. Fig. 5Real-time species typing (**a**) and strain typing (**b**) of a clinical isolate directly from the MinION using our pipeline and the Metrichor service. The time includes basecalling timing

Discussion {#Sec13}
----------

In recent years high-throughput sequencing has become an integrative tool for infectious disease research \[[@CR23], [@CR24]\], predominantly using massively parallel short-read sequencing technologies. These technologies achieve a very high base calling accuracy, making them ideally suited to applications requiring accurate calling of SNPs. However, these technologies attain their high yield by sequencing a single base per cycle for millions of sequence fragments in parallel, where each cycle takes at least 5 min.

The Oxford Nanopore MinION device, on the other hand, generated as many as 500 reads in the first 10 min of sequencing in our hands (which is 3 times lower than the theoretical maximum). The error rate of these reads was substantially higher than the corresponding Illumina short-read data. Many existing bioinformatics algorithms rely on accurate base and SNP calling, which makes their application to MinION data challenging. As an example, most existing strain typing approaches often use a MLST system, either on a pre-defined set of house keeping genes \[[@CR25]\], or on core genes set \[[@CR26]\]. These approaches are highly standardised, reproducible and portable, and hence are routinely used in laboratories around the world. Rapid genomic diagnosis tools using MLST from high-throughput sequencing such as SRST2 \[[@CR27]\] have also been developed. While we showed in this article that MLST can be adapted to identify bacterial strains from nanopore sequencing, this requires high coverage sequencing of the gene set to overcome the high error rates.

The main contribution of this article is to demonstrate that despite the higher error rate, it is possible to return clinical actionable information, including species and strain identification from as few as 500 reads. We achieved this by developing novel approaches that are less sensitive to base-calling errors and which use whatever subset of genome-wide information is observed up to a point in time, rather than a panel of pre-defined markers or genes. For example, the strain typing presence/absence approach relies only on being able to identify homology to genes and also allows for a level of incorrect gene annotation.

Our strain typing module has the advantage of being able to rapidly type a known strain with a small number of low quality (*i.e.*, mostly 1D) reads. Competing approaches using k-mers appear to require substantially more high quality data. The drawback of our approach is that if a large number of genes are lost or gained in a single event, such as the gain or loss of a plasmid, the most likely strain may be incorrect. Thus it would be ideally suited for rapidly typing a known strain in an outbreak scenario.

Our antibiotic resistance module is able to identify the drug resistance potential of an isolate within a few hours of sequencing with very high specificity. In particular, with the most recent chemistry utilised in this paper (R7.3), we were able to identify the complete resistance potential of a *K. pneumoniae* isolate without any false positives in 9.5 h, and with approximately 8000 reads, (80 % of the resistance genes were identified with 3000 reads in 2 h). In order to achieve high specificity we designed a probabilistic Finite State Machine for error correction.

One of the major advantages of a whole-genome sequencing approach to drug resistance profiling is that it is not necessary to restrict the analysis to a limited panel of drug-resistance tests, but it is possible to discover the complete drug resistance profile in a sample. With a complete picture of the drug-resistance profile within a few hours, a clinician may be able to design an antibiotic treatment regimen that is both more likely to succeed and less likely to induce further antibiotic resistance. However, even achieving completely accurate identification of resistance genes is only a first step in accurately predicting the resistance profile, as mutations may effect the rate at which these genes are transcribed and also their antibiotic resistance activity. Prediction of antibiotic resistance from genotype is an area that warrants substantial further research.

In summary, we have developed an open-source, flexible pipeline for real-time analysis of MinION sequencing data. The pipeline includes various streaming algorithms to identify pathogens and their antibiotic resistance, but others can be seamlessly integrated into \[[@CR28]\]. The only step in our pipeline at which data are written to, and then re-read from disk is the base-calling step using Metrichor. npReader immediately identifies new reads as they are generated by Metrichor; however, some delay can occur while waiting for base-called data to be returned from Metrichor. Oxford Nanopore Technologies have recently opened up the Application Programming Interface to extract raw data directly from the MinION. This, together with the recent development of open source base-calling algorithms \[[@CR29], [@CR30]\] to run on the local machine, will allow future development of a completely streaming pipeline, in the sense of never saving data to disk. Our pipeline can be deployed on a single 16 core computer, capable of analysing MinION data streaming at up to 120 × the current rate of sequencing; or on a high performance computing cluster to scale with the potential even higher throughput of forthcoming nanopore sequencing platforms.

Methods {#Sec14}
=======

DNA extraction {#Sec15}
--------------

Bacterial strains *K. pneumoniae* ATCC BAA-2146, ATCC 13883, *K. quasipneumoniae* ATCC 700603, *E. coli* ATCC 25922 and *S. aureus* ATCC 25923 were obtained from the American Type Culture Collection (ATCC, USA). *K. pneumoniae* clinical isolate was acquired from Hygeia General Hospital, Athens, Greece from a patient stool sample in 2014 (Lab ID 100575214, isolate 1). Clinical susceptibility profiling by VITEK®;2 (bioMérieux Inc.) identified the isolate as carbapenemase-producing (KPC), giving rise to extended spectrum *β*-lactam resistance. It was also deemed resistant to aminoglycoside, phenicol, quinolone, sulphonamide, tetracycline and trimethoprim antibiotics, rendering it an extensively drug-resistant bacterial isolate. Bacterial cultures were grown overnight from a single colony at 37 °C with shaking (180 rpm). Whole cell DNA was extracted from the cultures using the DNeasy Blood and Tissue Kit (QIAGEN Ⓒ, Cat \#69504) according to the bacterial DNA extraction protocol with enzymatic lysis pre-treatment.

MinION sequencing {#Sec16}
-----------------

Library preparation was performed using the Genomic DNA Sequencing kit (Oxford Nanopore) according to the manufacturer's instruction. For the R7 MinION Flow Cells SQK-MAP-002 sequencing kit was used and for R7.3 MinION Flow Cells SQK-MAP-003 or SQK-MAP-006 Genomic Sequencing kits were used according to the manufacturer's instruction.

For the library mixture sample, the DNA concentration of each library was measured using Qubit Fluorimeter (Thermo Fisher Scientific). Based on the concentration, 75 % of *E. coli* (ATCC 25922) library and 25 % of *S. aureus* (ATCC 25923) library were mixed prior to sequencing.

A new MinION Flow Cell (R7 or R7.3) was used for sequencing each sample. The library mix was loaded onto the MinION Flow Cell and the Genomic DNA 48 h sequencing protocol was initiated on the MinKNOW software.

MinION data analysis {#Sec17}
--------------------

The sequence read data were base-called with Metrichor Agent. We used npReader \[[@CR10]\] to convert base-called sequence data in fast5 format to fastq format. The npReader program also extracted the time that each read was sequenced and used this information to sort the read sequences in order they were produced. For the real-time analyses, we wrote a program to emulate the sequencing process in that it streamlined each read in the exact order it was sequenced. The program also allowed us to scale up the sequencing emulation to a factor of choice. Our pipeline allows for filtering out 1D reads at multiple stages (including via npReader). All subsequent analyses in this paper used both 1D and 2D reads.

MiSeq sequencing and data analysis {#Sec18}
----------------------------------

Library preparation was performed using the NexteraXT DNA Sample preparation kit (Illumina), as recommended by the manufacturer. Libraries were sequenced on the MiSeq instrument (Illumina) with 300 bp paired end sequencing, to a coverage of over 100-fold. Read data were trimmed with *trimmomatic* \[[@CR31]\] (V0.32) and subsequently assembled using SPAdes \[[@CR32]\] (V3.5), resulting in assemblies with N50 exceeding 200 Kb. Their sequence types were identified by submitting the assembled genomes to the MLST servers \[[@CR33]\] for *K. pneumoniae*, *E. coli* (set \#1) and *S. aureus*.

We identified the antibiotic resistance profiles of these strains from their MiSeq assemblies. We used blastn (V2.29)to align these assemblies to the database of resistance genes obtained from ResFinder \[[@CR17]\]. Genes that were covered at least greater than 85 % by the alignments and with greater than 85 % sequence identity were considered to be present in the sample. These gene profiles were used as a benchmark to validate the MinION sequencing analysis.

Species typing {#Sec19}
--------------

We downloaded the bacterial genome database on GenBank (accessed 19 Nov 2014), which contained high quality complete genomes of 2785 bacterial strains from 1487 bacteria species. We expanded this database to include two *K. quasipneumoniae* genomes. Our species typing pipeline streamed read data from npReader directly to BWA-MEM \[[@CR11]\] (V0.7.10-r858), which aligned the reads to the database. Output from BWA in SAM format was streamed directly into our species typing pipeline, which calculated the proportion of reads aligned to each of these species. Our species typing method considers the proportions {*p*~1~,*p*~2~,..,*p*~*k*~} of *k* species in the mixture as the parameters of a *k*-category multinomial distribution, and the read counts {*c*~1~,*c*~2~,..,*c*~*k*~} for the species as an observation from *c*~1~+*c*~2~+..+*c*~*k*~ independent trials drawn from the distribution. It then uses the MultinomialCI package in R \[[@CR34]\] to calculate the 95 % confidence intervals of these proportions from the observation.

Multi-locus sequence typing {#Sec20}
---------------------------

MinION sequence reads from *K. pneumoniae* strains were aligned to the seven house-keeping genes specified by the MLST system using BWA-MEM \[[@CR11]\]. We then collected reads that were aligned to a gene and performed a multiple alignment on them using kalign2 \[[@CR35]\]. The consensus sequence created from the multiple alignment was then globally aligned to all alleles of the gene using a probabilistic Finite State Machine (see below) for global alignment. The score of a sequence type was determined by the sum of the scores of seven alleles making up the type.

Strain typing {#Sec21}
-------------

We built gene profile databases for *K. pneumoniae*, *E. coli* and *S. aureus* from the RefSeq annotation. Specifically, we obtained the publicly available assemblies of these species listed on the RefSeq (accessed 17 July 2015). We used the relevant MLST schemes obtained from \[[@CR33]\] to identify sequence type of each assembly. For each sequence type, we selected the assembly with highest N50 statistic and use the RefSeq gene annotation of the assembly to determine the gene content of the sequence type.

In order to develop a simple probabilistic presence/absence strain typing model, we considered the genomes of each of the strains simply as a collection of genes. Denote by *St*~*j*=1..*J*~ all the strains in our database (for a fixed species). Denote by *g*~*j*,*k*~ the *k*^*th*^ gene in the database for strain *j*, where the genes are listed in no particular order. Denote by *N*~*j*~ the total number of genes in *St*~*j*~.

We aligned each sequence read *r*~*i*~ from the MinION device to the gene database using BWA-MEM \[[@CR11]\]. We counted the number of genes of each strain that aligned to read *r*~*i*~, denoted by *N*~*j*~(*r*~*i*~).

We describe below how to calculate the likelihood, *P*(*r*~*i*~\|*St*~*j*~), of each strain generating each read, from which we can calculate the posterior probability of each strain *St*~*j*~ conditional on observing the reads *r*~1~...*r*~*m*~: $$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document} $$ P({St}_{j}|r_{1}..r_{m}) = \frac{\prod_{i=1..m}P(r_{i}|{St}_{j})}{\sum_{j'}\prod_{i=1..m}P(r_{i}|{St}_{j})}  $$ \end{document}$$

The probability *P*(*r*~*i*~\|*St*~*j*~) could be calculated using a simple model as: $$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document} $$ P_{\text{simple}}(r_{i} | {St}_{j}) = \frac{N_{j}(r_{i})}{N_{j}},  $$ \end{document}$$

However, this model suffers from the problem that if we observe any read that overlaps a gene not in the reference genome for *St*~*j*~, then the posterior probability of that strain will become zero. Thus, this model is very unstable. In order to make this estimate more stable, we used a mixture model that allows the read to have been generated by a background model: $$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document} $$ \begin{aligned} P(r_{i} | {St}_{j}) = (1-c)*\frac{N_{j}(r_{i})}{N_{j}} + (c)*P\left(r_{i} | \bigcup_{j'} {St}_{j'}\right). \end{aligned}  $$ \end{document}$$

The background model considers the probability that the read was generated from any of the strains: $$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document} $$  P\left(r_{i} | \bigcup_{j'} {St}_{j'}\right) = \frac{\sum_{j'} N_{j'}(r_{i})}{\sum_{j'} N_{j'}}.  $$ \end{document}$$

This makes the posterior probability estimates more stable. It also makes the model robust to incorrect annotation of the reads from the MinION sequencer and incorrect annotation of the reference genome. We have investigated use of *c*=0.2, *c*=0.1 and *c*=0.05 and found that it has little impact on the results, with slightly smaller confidence intervals (data not shown). We chose *c*=0.2 in order to conservatively estimate confidence intervals.

Finally, in order to calculate confidence intervals we employed a bootstrap resampling approach in which we resampled *m* reads from *r*~1~,...*r*~*m*~ with replacement. This is repeated 1000 times, and the posterior probabilities are recalculated every iteration. We calculated the 95 % confidence intervals from the empirical distribution of these posterior probabilities.

To gain some insight into how this model works in response to gene presence, consider a gene *g*, which is present in a fraction *f* of strains, including *St*~*j*~ but not including *St*~*k*~. For simplicity, assume that each strain has *N* genes. The difference in log-likelihood *St*~*j*~ and *St*~*k*~ conditional on *g* can be approximated by log(1/*c*)+ log(1/*f*), showing that a more specific gene has a stronger effect in our model than a common gene in distinguishing strains.

To gain insight into the effect of gene absence in contrast to gene presence, assume instead that the only difference between *St*~*j*~ and *St*~*k*~ is the deletion of a single gene (*g*) in *St*~*j*~, and denote by *N*=*N*~*j*~=*N*~*k*~−1. If we sequence *N* ln(2) genes from *St*~*j*~ without seeing gene *g*, the difference in log-likelihood becomes *N* ln(2)∗(log(*N*)− log(*N*−1))≈1bit, corresponding to the likelihood that *St*~*j*~ is twice as big as the likelihood of *St*~*k*~. For example, if a strain has 1000 genes, then we would need to observe 693 genes without observing *g* to be able to conclude that the observed data were twice as likely to be generated from the species with a single gene deletion. For comparison, we would need to only sequence 100 genes from *St*~*k*~ to get an expected log-likelihood difference of 1 bits versus *St*~*j*~, demonstrating the extra information in gene 'presence' versus 'absence' typing.

Antibiotic resistance gene classes detection {#Sec22}
--------------------------------------------

We downloaded the resistance gene database from ResFinder \[[@CR17]\] (accessed July 2015). We aligned each gene to the collection of bacterial genomes in RefSeq using blastn \[[@CR36]\], and used the best alignment of the gene to extract 100 bp sequences flanking the antibiotic resistance genes. We found that the inclusion of these flanking sequences improved the sensitivity of mapping MinION reads to the gene database.

We then grouped these genes based on 90 % sequence identity into 609 groups. We manually checked and found that genes within a group were variants of the same gene. We selected the longest gene in each group to make up a reduced resistance gene database. To create a benchmark of resistance genes for a sample, we used blastn to compare the Illumina assembly of the sample against this reduced gene database, and reported genes with greater than 85 % coverage and identity.

Our analysis pipeline aligned MinION sequencing data to this reduced resistance gene database using BWA-MEM \[[@CR11]\] in a streamlined fashion, and examined genes with reads mapping to the whole gene (not including flanking sequences). Because of high error rates with MinION sequence data, we noticed a high rate of false positive genes. To reduce false positives, we used kalign2 \[[@CR35]\] to perform a multiple alignment of reads that were aligned to the same gene. The consensus sequence resulting from the multiple alignment was then compared with the gene sequence using a probabilistic Finite State Machine (see below). The pipeline then reported gene classes based on the genes detected.

Sensitive alignment of noisy sequences with probabilistic Finite State Machines {#Sec23}
-------------------------------------------------------------------------------

Our methods for MLST strain typing and antibiotic resistance gene identification require the alignment of a consensus sequence to a gene or a gene allele. Such an alignment generally assumes a model and a set of parameters of the differences between the sequences. It is widely recognised that the accuracy of the alignment is sensitive to these parameters \[[@CR37]--[@CR39]\]. However, in the context of real-time analysis of MinION sequencing, it is not possible to select in advance a sensible set of parameters. On the one hand, the quality among sequence reads differs remarkably; as shown in Additional file [1](#MOESM1){ref-type="media"}: Figure S1 and Table [2](#Tab2){ref-type="table"} -- the majority (95 %) of the reads across our four runs have a Phred score ranging between 3 and 7 for template and complement reads (corresponding to 50--80 % accuracy) and between 6 to 12 for 2D reads (75--95 % accuracy). On the other hand, a consensus sequence is computationally constructed from a set of reads. Its quality is hence contingent to not only the quality of the reads but also the number of reads in the set.

We use a probabilistic Finite State Machine (pFSM) \[[@CR40]\] to model the differences, and hence the simultaneous error profile of the consensus sequence. Briefly, a pFSM is a probabilistic model of genomic alignment that takes into account different types of variations including SNPs, insertions and deletions. A pFSM is equivalent to a hidden Markov Model. The pFSM consists of a set of states and transitions between states. Each transition corresponds to an *action* and is associated with a cost for the action. An action could be one of *copy* (*C*), *substitute* (*S*), *delete* (*D*) and *insert* (*I*). Figure [6](#Fig6){ref-type="fig"} depicts a three-state pFSM, which is equivalent to an affine gap penalty alignment model. In order to assess an alignment of two sequences A and B, under a hypothesis specified by the parameters, the pFSM computes the cost to generate one sequence (say A) given the other (B). For example, while in state *Copy*, the machine consumes the next base in B, generates the next base in A; it is said to take action *C* if the two bases are the same, or action *S* otherwise, and to follow either transition to state *Copy*. Alternatively, the machine can take either action *D* (consumes the next base in B without generating any base in A and moves to state *Delete*), or action *I* (generates the next base in A without consuming a base in B and moves to state *Insert*). These actions are repeated until the whole sequence B is generated. Fig. 6Schematic of a three-state probabilistic Finite State Machine

We used an information-theoretic measure whereby the cost of a transition is that of encoding the generated base, or in other words, the negative logarithm of the probability of the associated action (*c*=−*log*~2~(*P*(*a*)). The foundation of this approach goes back to the 1960s when it was proposed as a basis for inductive inference \[[@CR41], [@CR42]\]. It has since been used in several bioinformatics applications such as for calculating the BLOSUM matrix \[[@CR43]\] and modelling DNA sequences \[[@CR44], [@CR45]\]. More importantly, this information-theoretic framework allows one to estimate a sensible set of parameters for any *related* two sequences. This is done via an Expectation-Maximisation process. This starts with an initial set of probabilities at each state. In the E-step, the best alignment (lowest cost) is calculated by a dynamic programming algorithm. The frequencies of actions at each state are then used to re-estimate the probabilities in the M-step. A detailed discussion of this process is provided in Allison *et al* \[[@CR40]\] and Cao et al. \[[@CR46]\]. The process is guaranteed to converge to an optimal, and it does so in only a few iterations in our experience.
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